Bitcoin is hitting record highs, but a "silent bull run" has emerged with a 50% drop in active addresses. As institutions pivot to stablecoins and RWAs, retail investors remain sidelined by fatigue and AI stocks. Can the market recover without them?
The full text of the bipartisan Clarity Act is here. Aiming to establish the US as a Web3 hub, the bill clarifies the securities vs. commodities debate. With the Senate markup set for Thursday, discover how this landmark legislation impacts asset classification and your portfolio.
As the DOJ subpoenas Fed Chair Powell, institutional clashes threaten economic stability. Crypto markets face early 2026 volatility amid government shutdowns, yet analysts remain bullish on Bitcoin hitting new all-time highs once political headwinds subside.
The crypto market reaches a pivotal juncture as the Clarity Act nears completion and Bitcoin holds $92k. With whale longs hitting peaks and a rare altcoin MACD cross, the industry is bracing for a massive capital rotation.
Scott Galloway joins Kara Swisher to break down the DOJ’s probe into Jerome Powell—viewed by markets as a political play to influence rates. Plus, a look at Venezuelan oil economics and escalating tensions in Iran.
Applications are open for the 2026 Renée Fleming Neuroarts Investigator Awards. This initiative offers seed funding for collaborative projects between researchers and artists. Discover application details and insights from the recent webinar led by Susan Magsamen and Renée Fleming.
Marking the 10th anniversary of the Aspen Institute’s Initiative, experts urge a shift from tech hype to human agency. The narrative moves beyond automation fears to building infrastructure that supports worker power, data ownership, and shared prosperity in the coming decade.
As AI reshapes the workforce, anxiety over job loss and purposelessness is rising. In this dialogue, Tony Robbins and Peter Diamandis argue this isn't just an economic crisis but a "nervous system shock." Learn how to rewire your identity and find certainty from within to thrive.
Adam Carolla diagnoses California’s decline, attributing it to regulatory overreach and "gyno-fascism." He discusses the Palisades fire, the exodus to red states, and why a safety-obsessed governance style is paralyzing the state and driving a major political realignment.
In a major 2026 strategy shift, Meta pivots from the metaverse to AI wearables, aiming for 30 million Ray-Ban units. Meanwhile, Microsoft pledges to cover rising utility costs and forego tax incentives for data centers to ease community friction.
Apple officially adopts Google Gemini to power Siri and Apple Intelligence, shifting from internal development. Analysts maintain a $350 price target, viewing this collaboration as a critical step for Apple to monetize its user base and succeed in the AI revolution.
JPMorgan retains its #1 rank for AI deployment among Western banks. Analysis from Evident highlights a strategic shift to enterprise-wide scaling. As earnings season begins, investors are watching closely to see when these investments will yield substantial ROI.
Laffer Tengler CEO Nancy Tengler argues Meta must abandon its Metaverse strategy to unlock shareholder value. Calling the initiative a "distraction," she dismisses AI bubble fears and highlights the critical importance of physical infrastructure in the ongoing tech boom.
Klarna CEO Sebastian Siemiatkowski backs a proposal to cap credit card interest at 10%, calling the current US system an "extraction machine." He noted Americans paid $160 billion in interest last year and pledged Klarna would comply with the new mandates to protect consumers.
Apple selects Google Gemini to power Siri in a landmark $1 billion deal, briefly pushing Alphabet's market cap past $4 trillion. The partnership bridges the gap while Apple builds its own AI. Plus: Nvidia and Eli Lilly join forces on a new AI pharma lab.
Nvidia expands beyond hardware with a reported $1 billion investment in an AI drug lab alongside Eli Lilly. This strategic pivot from digital to "physical AI" aims to revolutionize healthcare, using advanced computing to tackle complex drug discovery challenges.
